Therapeutic stapled peptides: Efficacy and molecular targets

• Main Authors: Yulei Li (Author), Minghao Wu (Author), Yinxue Fu (Author), Jingwen Xue (Author), Fei Yuan (Author), Tianci Qu (Author), Anastassia N. Rissanou (Author), Yilin Wang (Author), Xiang Li (Author), Honggang Hu (Author)
• Format: Book
• Published: Elsevier, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 1096-1186; 10.1016/j.phrs.2024.107137
• Keywords: Staple peptide; Therapeutic peptide drug; α-helical peptide; Targets; Therapeutics. Pharmacology; RM1-950
• Source: Pharmacological Research, Vol 203, Iss , Pp 107137- (2024)

Peptide stapling, by employing a stable, preformed alpha-helical conformation, results in the production of peptides with improved membrane permeability and enhanced proteolytic stability, compared to the original peptides, and provides an effective solution to accelerate the rapid development of peptide drugs. Various reviews present peptide stapling chemistries, anchoring residues and one- or two-component cyclization, however, therapeutic stapled peptides have not been systematically summarized, especially focusing on various disease-related targets. This review highlights the latest advances in therapeutic peptide drug development facilitated by the application of stapling technology, including different stapling techniques, synthetic accessibility, applicability to biological targets, potential for solving biological problems, as well as the current status of development. Stapled peptides as therapeutic drug candidates have been classified and analysed mainly by receptor- and ligand-based stapled peptide design against various diseases, including cancer, infectious diseases, inflammation, and diabetes. This review is expected to provide a comprehensive reference for the rational design of stapled peptides for different diseases and targets to facilitate the development of therapeutic peptides with enhanced pharmacokinetic and biological properties.